Varicella Vaccination in Japan, South Korea, and Europe

Sadzot-Delvaux, Catherine; Rentier, Bernard; Wutzler, Peter; Asano, Yoshizo; Suga, Sadao; Yoshikawa, Tetsushi; Plotkin, Stanley A.
March 2008
Journal of Infectious Diseases;Mar2008 Supplement 2, Vol. 197, pS185
Academic Journal
The most extensive use of varicella vaccine has been in the United States and Canada, where it is universally recommended. However, a number of other countries now have recommendations for use of the vaccine, which has been expanding in Europe and Latin America. In this article, we review information concerning varicella vaccination in Japan, where the vaccine was first developed, and in South Korea and parts of Europe. Despite the worldwide availability of an efficient vaccine, varicella vaccination policy is highly variable from country to country. The recent development of a tetravalent vaccine against measles, mumps, rubella, and varicella could modify this variability in the future. It is evident that efforts to control varicella will spread gradually to all continents.


Related Articles

  • Varicella Immunogenicity with 1- and 2-Dose Regimens of Measles-Mumps-Rubella-Varicella Vaccine. Shinefield, Henry R.; Black, Steve; Kuter, Barbara J. // Journal of Infectious Diseases;Mar2008 Supplement 2, Vol. 197, pS152 

    A quadrivalent vaccine combining measles, mumps, rubella, and varicella antigens (MMRV) was developed to increase the coverage of varicella vaccine and reduce the number of injections children receive. Although the varicella antigen is as immunogenic in the latest formulation of MMRV vaccine as...

  • Varicella zoster virus vaccine live.  // Reactions Weekly;2/16/2008, Issue 1189, p34 

    The article describes the case of a male infant who acquired urticaria. The patient developed the disease after he was given a live varicella zoster virus vaccine. He was administered with oral prednisone. Diphenhydramine was given to the infant to treat pruritus. The patient also received...

  • Perspective on Live Varicella Vaccine. Gershon, Anne A.; Katz, Samuel L. // Journal of Infectious Diseases;Mar2008 Supplement 2, Vol. 197, pS242 

    The attenuation of varicella-zoster virus (VZV) by Takahashi in 1974 was a remarkable achievement. It swiftly led to development of a live vaccine against chickenpox, which was initially tested in Japan. With its successful employment in immunocompromised children to prevent morbidity and...

  • MMR-varicella zoster virus vaccine.  // Reactions Weekly;8/31/2013, Issue 1467, p28 

    The article discusses the case report of an 11-month-old boy who developed nonfebrile seizures after receiving an MMR-varicella zoster virus vaccine.

  • VARIVAX.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p2438 

    A definition of the term "VARIVAX," which refers to varicella virus vaccine live, is presented.

  • Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA. Fiebelkorn, Amy Parker; Lawler, Jacqueline; Curns, Aaron T.; Brandeburg, Christina; Wallace, Gregory S. // Emerging Infectious Diseases;Sep2013, Vol. 19 Issue 9, p1411 

    Although the measles-mumps-rubella (MMR) vaccine is not recommended for mumps postexposure prophylaxis (PEP), data on its effectiveness are limited. During the 2009-2010 mumps outbreak in the northeastern United States, we assessed effectiveness of PEP with a third dose of MMR vaccine among...

  • Independent Nurse: Journals watch - MMR vaccination rate shows slight recovery.  // GP: General Practitioner;9/30/2005, p78 

    The article reports that annual figures show the uptake of MMR vaccine in England has risen for the first time since 1995-96.

  • Will unlicensed drugs put you at legal risk? Norwell, Nicholas // Pulse;9/10/2005, Vol. 65 Issue 35, p40 

    Presents a question and answer advisory regarding the prescription of unlicensed Measles-mumps-rubella (MMR) vaccines. Safety issues related to the prescription of unlicensed MMR vaccines; Administration of unlicensed MMR under a Patient Group Direction; Disclosure of information to patients...

  • GP's parting shot at MP over MMR row.  // Pulse;9/10/2005, Vol. 65 Issue 35, p18 

    Reports on the launch of attack on Member of the Parliament Andrew Mackay's position of measles-mumps-rubella (MMR) vaccine by general practitioner George Kassianos of Berkshire, England. Refusal of the legislator to participate in a MMR publicity campaign; Impact of the MMR issue on practitioners.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics